Cisplatin, 5-fluorouracil, and high-dose folinic acid in patients with advanced unresectable head and neck cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 2, 1996, Pages 140-143

  Alba, Emilio ^a   Sánchez Chaparro, Miguel Angel ^a   Alonso, Lorenzo ^a   Ribelles, Nuria ^a   Delgado, Juan Ramón ^a   Rueda, Antonio ^a   Tenllado, Pedro Pablo ^a   Solano, José ^a   Urquiza, Rafael ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

5 Fluorouracil; Cisplatin; Folinic acid; Head neck cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTIDOTES; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEUTROPENIA; REMISSION INDUCTION; SURVIVAL RATE;

EID: 0029986694     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199604000-00010     Document Type: Article

References (13)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-94.
2. Rooney M, Kish J, Jacobs J, et al. Improved complete response rate and survival in advanced head and neck cancer after three course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 1985;55:1123-28.
3. Forastiere AA. Randomized trials of induction chemotherapy: a critical review. In: Hematol/Oncol Clin North Am 1991;5:725-36.
4. Toohill RJ, Anderson T, Byhardt RW, et al. Cisplatin and fluorouracil neoadjuvant in head and neck cancer. Arch Otolaryngol Head Neck Surg 1987;113:758-61.
5. Martin M, Hazan A, Vergnes L, et al. Randomized study of 5-fluorouracil and cisplatin as neoadjuvant therapy in head and neck cancer: a preliminary report. Int J Radiat Oncol Biol Phys 1990;19:973-5.
6. The Department of Veterans Affairs Laryngeal Cancer Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-90.
7. Urba S, Forastiere AA. Systemic therapy of head and neck carcinoma: most effective agents and areas of controversy. Oncology 1989;3:79-88.
8. Vokes EE, Choi KE, Schilsky RL, et al. Cisplatin, fluorouracil and high-dose leucovorin for recurrent or metastatic head and neck cancer. J Clin Oncol 1988;6:618-26.
9. Dreyfuss A, Clark JR, Wright JE, et al. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med 1990;112:167-72.
10. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
11. Clark JR, Dreyfuss A, Busse P, et al. Neoadjuvant continuous infusion cisplatin, 5-FU and high-dose leucovorin (PFL) for squamous cell carcinoma of the head and neck: high rates of complete response and definitive radiotherapy as primary site management [Abstract]. Proceedings of the Fourth International Congress on Anticancer Chemotherapy 1993;4:66.
12. Vokes EE, Weichselbaum RR, Mick R, et al. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 1992;84:877-82.
13. Fonseca E, Cruz JJ, García J, et al. Induction chemotherapy with cisplatin, 5-fluorouracil and folinic acid in locally advanced head and neck cancer [Abstract]. Proceedings of the Fourth International Congress on Anticancer Chemotherapy 1993;4:67.